Literature DB >> 7181523

Effect of indomethacin on clinical progress and renal function in cystinosis.

G B Haycock, J Al-Dahhan, R H Mak, C Chantler.   

Abstract

Three children with nephropathic cystinosis were treated with indomethacin 3 mg/kg a day for periods ranging from 9 to 18 months. The drug produced worthwhile clinical improvement in all, with marked beneficial effects on polyuria, polydipsia, and general wellbeing. Clearance studies performed under conditions of maximal water diuresis showed that proximal tubular sodium reabsorption was increased in all children, with consequent reduction in sodium delivery to the distal nephron leading to reduced free water clearance and distal tubular cation exchange. Plasma sodium and potassium concentrations became normal in all patients, with improvement in phosphate and bicarbonate concentrations in one. Renal function continued to deteriorate, but without obvious acceleration of the process by the drug. We were unable to demonstrate a beneficial effect on growth; nevertheless, indomethacin is a useful adjunct to the symptomatic treatment of children with severe nephropathic cystinosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7181523      PMCID: PMC1628080          DOI: 10.1136/adc.57.12.934

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  20 in total

1.  Depletion of cystine in cystinotic fibroblasts by drugs enclosed in liposomes.

Authors:  J D Butler; F Tietze; F Pellefigue; S P Spielberg; J D Schulman
Journal:  Pediatr Res       Date:  1978-01       Impact factor: 3.756

2.  Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin.

Authors:  R Verberckmoes; B van Damme B; J Clement; A Amery; P Michielsen
Journal:  Kidney Int       Date:  1976-03       Impact factor: 10.612

3.  Effect of chronic salt and water loading on the tubular defects of a child with Fanconi syndrome (cystinosis).

Authors:  B S Arant; I Greifer; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-09       Impact factor: 7.124

Review 4.  Cystinosis: a review.

Authors:  J A Schneider; J D Schulman
Journal:  Metabolism       Date:  1977-07       Impact factor: 8.694

Review 5.  Prostaglandins and renal function.

Authors:  J C McGiff; K Crowshaw; H D Itskovitz
Journal:  Fed Proc       Date:  1974-01

6.  [Evaluation of the dietary treatment of cystinosis].

Authors:  H Schmidt; P Lutz; H Bickel
Journal:  Monatsschr Kinderheilkd       Date:  1973-05

7.  Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man.

Authors:  R V Patak; B K Mookerjee; C J Bentzel; P E Hysert; M Babej; J B Lee
Journal:  Prostaglandins       Date:  1975-10

8.  Cystinotic rickets treated with vitamin D metabolites.

Authors:  P Etches; D Pickering; R Smith
Journal:  Arch Dis Child       Date:  1977-08       Impact factor: 3.791

9.  Penicillamine treatment of cystinosis.

Authors:  L Hambraeus; O Broberger
Journal:  Acta Paediatr Scand       Date:  1967-05

10.  The effect of indomethacin on kidney function and plasma renin activity in man.

Authors:  A J Donker; L Arisz; J R Brentjens; G K van der Hem; H J Hollemans
Journal:  Nephron       Date:  1976       Impact factor: 2.847

View more
  11 in total

1.  Effects of oral phosphocysteamine and rectal cysteamine in cystinosis.

Authors:  W G van't Hoff; T Baker; R N Dalton; L C Duke; S P Smith; C Chantler; G B Haycock
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

2.  Interaction between galectin-3 and cystinosin uncovers a pathogenic role of inflammation in kidney involvement of cystinosis.

Authors:  Tatiana Lobry; Roy Miller; Nathalie Nevo; Celine J Rocca; Jinzhong Zhang; Sergio D Catz; Fiona Moore; Lucie Thomas; Daniel Pouly; Anne Bailleux; Ida Chiara Guerrera; Marie-Claire Gubler; Wai W Cheung; Robert H Mak; Tristan Montier; Corinne Antignac; Stephanie Cherqui
Journal:  Kidney Int       Date:  2019-03-06       Impact factor: 10.612

Review 3.  Update on nephropathic cystinosis.

Authors:  J A Schneider; B Katz; R B Melles
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

4.  Long-term outcome of nephropathic cystinosis: a 20-year single-center experience.

Authors:  Marcella Greco; Milena Brugnara; Marco Zaffanello; Anna Taranta; Anna Pastore; Francesco Emma
Journal:  Pediatr Nephrol       Date:  2010-08-29       Impact factor: 3.714

5.  Infantile cystinosis and insulin-dependent diabetes mellitus.

Authors:  A Ammenti; A Grossi; S Bernasconi
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

6.  Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders.

Authors:  H W Seyberth; S J Königer; W Rascher; P G Kühl; H Schweer
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

7.  Nephropathic cystinosis: an international consensus document.

Authors:  Francesco Emma; Galina Nesterova; Craig Langman; Antoine Labbé; Stephanie Cherqui; Paul Goodyer; Mirian C Janssen; Marcella Greco; Rezan Topaloglu; Ewa Elenberg; Ranjan Dohil; Doris Trauner; Corinne Antignac; Pierre Cochat; Frederick Kaskel; Aude Servais; Elke Wühl; Patrick Niaudet; William Van't Hoff; William Gahl; Elena Levtchenko
Journal:  Nephrol Dial Transplant       Date:  2014-09       Impact factor: 5.992

8.  Tubular dysfunction in type I diabetes mellitus.

Authors:  M Miltényi; A Körner; T Tulassay; A Szabó
Journal:  Arch Dis Child       Date:  1985-10       Impact factor: 3.791

9.  The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism.

Authors:  Arvand Haschemi; Paul Kosma; Lars Gille; Charles R Evans; Charles F Burant; Philipp Starkl; Bernhard Knapp; Robert Haas; Johannes A Schmid; Christoph Jandl; Shahzada Amir; Gert Lubec; Jaehong Park; Harald Esterbauer; Martin Bilban; Leonardo Brizuela; J Andrew Pospisilik; Leo E Otterbein; Oswald Wagner
Journal:  Cell Metab       Date:  2012-06-06       Impact factor: 27.287

10.  Multidisciplinary approach for patients with nephropathic cystinosis: model for care in a rare and chronic renal disease.

Authors:  Maria Helena Vaisbich; Carla Aline Fernandes Satiro; Deborah Roz; Debora de Almeida Domingues Nunes; Ana Carola H Lobo Messa; Camila Lanetzki; Juliana Caires de Oliveira Achili Ferreira
Journal:  J Bras Nefrol       Date:  2018-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.